DMED — Diagnamed Holdings Share Price
Last trade - 00:00- CA$6.55m
- CA$6.46m
- 13
- 27
- 67
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DiagnaMed Holdings Corp. is a Canada-based healthcare technology company. The Company delivers technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and artificial intelligence (AI)-driven drug discovery and diagnostics. The Company is focused on the commercialization of two technologies, such as a proprietary electromagnetic heating technology enabling hydrogen production from petroleum reservoirs and natural hydrogen fields, and BRAIN AGE BRAIN HEALTH, a proprietary brain health AI platform for the healthcare market. Its Brain Tremor is an investigating technological application that monitors, collects and uses individual information to detect tremors, and measure cognitive and brain activity in patients with neurological disorders. BRAIN AGE Brain Health is a brain health AI platform that aims to predict and monitor brain age and provide actionable insights into mental health and neurodegenerative disorders.
Directors
- Last Annual
- September 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- April 16th, 2021
- Public Since
- November 8th, 2022
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 109,158,973
- Address
- Suite 2900, 550 Burrard Street, VANCOUVER, V6C 0A3
- Web
- https://www.diagnamed.com/
- Phone
- +1 7786834324
- Auditors
- CLEARHOUSE LLP
Similar to DMED
AI/ML Innovations
Canadian Securities Exchange
Aleen
Canadian Securities Exchange
AlphaGen Intelligence
Canadian Securities Exchange
Anonymous Intelligence
Canadian Securities Exchange
Apartmentlove
Canadian Securities Exchange
FAQ
As of Today at 02:14 UTC, shares in Diagnamed Holdings are trading at CA$0.06. This share price information is delayed by 15 minutes.
Shares in Diagnamed Holdings last closed at CA$0.06 and the price had moved by +300% over the past 365 days. In terms of relative price strength the Diagnamed Holdings share price has outperformed the Toronto Stock Exchange 300 Composite Index by +233.43% over the past year.
There is no consensus recommendation for this security.
Find out moreDiagnamed Holdings does not currently pay a dividend.
Diagnamed Holdings does not currently pay a dividend.
Diagnamed Holdings does not currently pay a dividend.
To buy shares in Diagnamed Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.06, shares in Diagnamed Holdings had a market capitalisation of CA$6.55m.
Here are the trading details for Diagnamed Holdings:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: DMED
Based on an overall assessment of its quality, value and momentum Diagnamed Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Diagnamed Holdings. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +122.23%.
As of the last closing price of CA$0.06, shares in Diagnamed Holdings were trading +102.7% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Diagnamed Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Diagnamed Holdings' directors